Rainbow Institute makes rare discovery in fetal heart research

Text size 100%

Hyderabad: The Rainbow Children’s Heart Institute has made a significant medical breakthrough by successfully using direct fetal immunotherapy to treat a rare heart condition known as immune-mediated fetal myocarditis in unborn babies. This achievement, highlighted in JACC: Case Reports, positions the Hyderabad institute among a select few worldwide to successfully perform this complex procedure before birth.

Five fetuses, aged between 21 and 27 weeks of gestation, were diagnosed with severe heart disease caused by maternal antibodies. Traditional treatments given to the mothers were not effective. Therefore, doctors decided to administer immunotherapy directly to the fetuses with the help of advanced imaging technology. After receiving the treatment, all five fetuses showed significant improvement in heart function, rhythm normalization, and reduced fluid buildup.

Also read:  Apple Outage Hits Millions, Cyberattack Targets CNN And BBC, And Ukraine Hits Kerch Bridge

All of these babies were born alive and have remained stable, providing new hope to families dealing with complicated prenatal heart conditions.

Advertisement
Corrections Disclaimer: For article corrections, please email [email protected] or fill out the Grievance Resolution form
Nikhil Reddy
Written by

Nikhil Reddy

Reader poll

KCR / KTR / Harish Rao
Revanth Reddy
Others

Reader polls are not scientific surveys and show only the views of readers who chose to vote.

Leave a Reply

Your email address will not be published. Required fields are marked *